Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-1110-03 single-dose tablet pharmacokinetics in healthy Japanese males
jRCT2071240014Phase 1Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ONO-1110 in None, sponsored by Ono Pharmaceutical. Primary endpoint: Plasma ONO-1110 concentrations and pharmacokinetic parameters. Started Jun 2024; status: completed.
02
Drugs
ONO-1110
Beyond the preview
Go deeper on jRCT2071240014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071240014.